Advertisement

Topics

Stem Cell Sciences plc Company Profile

16:02 EST 17th November 2017 | BioPortfolio

Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce that two independent laboratories in the UK and USA have achieved germ-line transmission from embryonic stem (ES) cells in rats using technologies exclusively licensed to the company by Edinburgh University. This is believed to be the first time that germ-line transmission from rat ES cells has been demonstrated, and full scientific reports on this breakthrough, which has been independently verified, have been submitted to a major scientific journal for publication.


News Articles [2621 Associated News Articles listed on BioPortfolio]

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...

The protein TAZ sends 'mixed signals' to stem cells

(University of Southern California - Health Sciences) Just as beauty exists in the eye of the beholder, a signal depends upon the interpretation of the receiver. According to new USC research publishe...

U.S. Stem Cell: New Study Underscores The Safety Of Autologous Stem Cell Therapy In Degenerative Diseases And Injuries

SUNRISE, FL / ACCESSWIRE / October 11, 2017 / U.S. Stem Cell, Inc. (OTCQB: USRM), a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies f...

U.S. Stem Cell Clinic Launches Blog To Educate Consumers On The Power Of Stem Cell Therapy

SUNRISE, FL / ACCESSWIRE / September 20, 2017 / U.S. Stem Cell Clinic (USCC), a privately-held Florida LLC and leader in novel regenerative medicine solutions and physician-based stem cell therapie...

FDA Cracks Down on Stem Cell Clinics to Weed Out 'Bad Actors'

The FDA warns stem cell clinics in Florida and California about unapproved stem cell products and announces plans to step up oversight of stem cell clinics. News Alerts

FDA Warns About Stem Cell Therapies

Stem cells have been called everything from cure-alls to miracle treatments. But don't believe the hype. The U.S. Food and Drug Administration is concerned that some patients may be vulnerable to stem...

A new role for insulin as a vital factor in maintaining stem cells

(University of Copenhagen The Faculty of Health and Medical Sciences) When large amounts of insulin are around, stem cells retain their ability to make all the cell types in the body. However, too lit...

USC Stem Cell discovery refreshes the heart

(University of Southern California - Health Sciences) Some people are better than others at recovering from a wounded heart, according to a new USC Stem Cell study published in Nature Genetics.

PubMed Articles [6070 Associated PubMed Articles listed on BioPortfolio]

Lineage Tracing: Papers and Progress.

This i3 is a data visualization based on the Cell Stem Cell tenth anniversary theme of lineage tracing. Using Scopus citations of Cell Stem Cell research papers, it illustrates both the evolution of t...

Stem Cells: All that Is Solid Melts into Air.

The intestinal epithelium displays great resilience, as several cell populations can replenish the stem cell pool upon damage. Two studies in Cell Stem Cell extend this capacity to enteroendocrine cel...

Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling.

To investigate the role of SATB2 in stem cell-like properties of osteosarcoma and identify new strategies to eliminate cancer stem cells of osteosarcoma.

Biomaterial stiffness determines stem cell fate.

Stem cells have potential to develop into numerous cell types, thus they are good cell source for tissue engineering. As an external physical signal, material stiffness is capable of regulating stem c...

Metabolic Teamwork in the Stem Cell Niche.

Nearby cells can support stem cell differentiation, but the metabolic activities in stem cell niches are unknown. A recent study (Rodríguez-Colman et al., 2017) reveals a metabolic partnership in th...

Clinical Trials [6727 Associated Clinical Trials listed on BioPortfolio]

Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

The investigators hypothesize that this study will show that sufficient lymphocyte stem cell can be harvested prior chemoradiation and be reinfused back after treatment, and at least 5 of ...

Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation

The purpose of this study is to find out if getting a blood stem cell transplant with donor stem cells given over several days is better than getting a blood stem cell transplant with dono...

Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma

RATIONALE: It is not yet known which method of stem cell collection is best for patients undergoing an autologous stem cell transplant. PURPOSE: This randomized phase III trial is compari...

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Peripheral stem cell transplantation may be able to replace immune ...

Stem Cell Transplantation for Patients With Multiple Myeloma

The purpose of this study is to test whether regulatory T-cell reduction is possible and safe in myeloma subjects undergoing autologous stem cell transplantation (ASCT).

Companies [2031 Associated Companies listed on BioPortfolio]

Stem Cell Sciences plc

Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce that two independent laboratories in the UK ...

Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network. The company offers ge...

National Stem Cell Foundation

The National Stem Cell Foundation (NSCF) is a charitable 501(c)3 organization that funds adult stem cell and regenerative medicine research to accelerate treatment options, advoca...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

The New York Stem Cell Foundation

The New York Stem Cell Foundation (NYSCF) is an independent organization founded in 2005 to accelerate cures and better treatments for patients through stem cell research. NYSCF, ...

More Information about "Stem Cell Sciences plc" on BioPortfolio

We have published hundreds of Stem Cell Sciences plc news stories on BioPortfolio along with dozens of Stem Cell Sciences plc Clinical Trials and PubMed Articles about Stem Cell Sciences plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stem Cell Sciences plc Companies in our database. You can also find out about relevant Stem Cell Sciences plc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record